NantHealth, Inc.
NHIQ
$0.05
$0.0494,900.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -1.92% | 8.21% | 7.71% | 6.98% | 0.50% |
| Total Other Revenue | -60.00% | -85.71% | -85.00% | -86.96% | -91.53% |
| Total Revenue | -1.93% | 8.18% | 7.68% | 6.95% | 0.42% |
| Cost of Revenue | -0.11% | 1.92% | 5.59% | 4.51% | 1.33% |
| Gross Profit | -2.94% | 11.83% | 8.88% | 8.34% | -0.08% |
| SG&A Expenses | -8.92% | 10.73% | 17.70% | 19.98% | 23.24% |
| Depreciation & Amortization | -38.41% | -25.61% | -12.79% | 0.01% | 0.02% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.84% | 5.55% | 11.12% | 14.27% | 15.38% |
| Operating Income | 22.47% | -2.02% | -16.04% | -25.50% | -43.21% |
| Income Before Tax | -20.20% | -23.91% | -9.25% | -16.47% | 4.89% |
| Income Tax Expenses | -563.16% | -464.44% | -310.40% | -426.80% | -80.61% |
| Earnings from Continuing Operations | -19.64% | -23.13% | -8.57% | -15.73% | 5.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -101.64% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -100.00% |
| Net Income | -19.63% | -23.27% | -8.96% | -16.34% | 4.59% |
| EBIT | 22.47% | -2.02% | -16.04% | -25.50% | -43.21% |
| EBITDA | 32.57% | -2.85% | -18.96% | -29.71% | -51.69% |
| EPS Basic | -7.20% | -23.17% | -8.62% | -14.84% | 6.88% |
| Normalized Basic EPS | -3.32% | -24.39% | -9.81% | -15.51% | 5.14% |
| EPS Diluted | -8.12% | -24.13% | -9.53% | -15.74% | 7.56% |
| Normalized Diluted EPS | -3.32% | -24.39% | -9.81% | -15.51% | 5.14% |
| Average Basic Shares Outstanding | 23.74% | 0.09% | 0.32% | 1.23% | 2.16% |
| Average Diluted Shares Outstanding | 23.74% | 0.09% | 0.32% | 1.23% | 2.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |